Max Wolff is a psychologist and clinical researcher at the MIND Foundation. His research is concerned with processes of behavioral change and the psychological mechanisms underlying the efficacy of psychedelic-assisted treatments for mental disorders. As a psychotherapist he works with cognitive-behavioral, emotion-focused, and acceptance-based approaches. Max coordinates the MIND Foundation’s APT – Augmented Psychotherapy Training, and he is a committee member at the Mental Health Section within the MIND Members Association. He also works as a study therapist in the EPIsoDE study, a randomized-controlled trial investigating the safety and efficacy of psilocybin for treatment-resistant depression at the Central Institute of Mental Health in Mannheim, Germany, and Charité University Medicine Berlin.